Breaking News, Promotions & Moves

Catalent Appoints Corporate Development and Science Leaders

Mike Grippo will serve as senior vice president, Strategy and Corporate Development, and Julien Meissonnier as vice president and chief scientific officer

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent has appointed Mike Grippo as senior vice president, Strategy and Corporate Development. In this newly created role, Mr. Grippo will be responsible for identifying and evaluating growth opportunities across the company that will drive long-term shareholder value. He will report to John Chiminski, Catalent’s chair and chief executive officer.    Mike Grippo of Catalent Mr. Grippo joined Catalent as vice president of Corporate Development in 2016, and in his new role will ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters